Peptides DB
Research-centric peptide and protocol reference hub

Research library

Every indexed study on every peptide in the database, with a machine summary and the numbers that matter pulled out. Filter on the left; the register updates as you go.

2423studies indexed1086with human data145registered trials2091carry a numeric findingLibrarian added 0 studies today
Showing 14 studiesSortNewest indexed ▾
B
grade
<sup>124</sup>Iodine Evuzamitide Positron Emission Tomography in Patients with Established or Suspected Cardiac Amyloidosis.
Evuzamitide · JACC. Cardiovascular imaging · 2026 · Observational
124I-evuzamitide PET imaging shows high diagnostic accuracy for cardiac amyloidosis, with 100% sensitivity and specificity in this study.
Mean LV/blood pool standardized uptake value ratio (SUVRmean) was 1.89 ±0.29 in patients with CA and 0.91 ±0.15 in patients without CA, p<0.001.
D
grade
Evaluating AI in postoperative rehabilitation of axillary web syndrome after breast cancer surgery: ChatGPT vs DeepSeek.
Evuzamitide · Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology · 2026 · Observational
DeepSeek outperformed ChatGPT in rehabilitation decision support for axillary web syndrome, but findings should be interpreted with caution due to the limited case number.
DeepSeek performed significantly better than ChatGPT in diagnostic accuracy (p=0.006).
A
grade
Design and rationale of the Research with EVuzamitide to Evaluate for cardiac AmyLoidosis (REVEAL) positron emission tomography study: A study of (124)I-evuzamitide to diagnose cardiac amyloidosis.
Evuzamitide · Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2026 · RCT
The REVEAL trial is designed to evaluate a new imaging method for diagnosing cardiac amyloidosis, but results are not yet available.
Not reported in abstract.
Showing 14 of 14